PLIANT THERAPEUTICS, INC. - COM (PLRX)

Historical Portfolio Holders from Q2 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
63.5M
Holdings value Q3 2024
$714M
Value change Q3 2024
-$5.61M
Grand Portfolio weight change Q3 2024
0%
Number of holders
149
Number of buys Q3 2024
82
Number of sells Q3 2024
-46
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 63.5M $714M -$5.61M $11.21 150
2024 Q2 63.9M $687M -$18.5M $10.75 142
2024 Q1 65.2M $971M +$41.5M $14.90 134
2023 Q4 62.7M $1.14B +$101M $18.11 133
2023 Q3 60.2M $1.04B +$29.4M $17.34 135
2023 Q2 58M $1.05B +$9.42M $18.12 141
2023 Q1 56.2M $1.5B +$313M $26.60 143
2022 Q4 44.7M $864M -$14.8M $19.33 123
2022 Q3 45.4M $948M +$327M $20.89 107
2022 Q2 30.1M $241M -$11.2M $8.01 82
2022 Q1 31.4M $220M +$4.11M $7.01 85
2021 Q4 30.9M $416M +$5.47M $13.50 81
2021 Q3 30.4M $513M -$14.9M $16.88 75
2021 Q2 30.7M $893M -$1.36M $29.12 80
2021 Q1 30.7M $1.21B +$88.1M $39.33 76
2020 Q4 28.5M $648M +$7.27M $22.72 57
2020 Q3 28.2M $636M +$17M $22.65 53
2020 Q2 26.9M $868M +$868M $32.46 36